Skip to content

Dr. Katrien Van de Steen

Active Private limited companyfounded 2022active for 4 yearsDr. A. Robrechtsstraat 21, 2250 OlenKBO/BCE: BE 0791.596.214

Lifetime

3 annual accounts with figures on one time axis
peak of €65,794 in 2024
€3,150▼ 95.2%
lowest -€1,278 in 2025
-€1,278▼ €48,359
peak of €91,579 in 2024
€90,302▼ 1.4%
€16,360▼ 65.5%
Board1 name since 2022
1 director
Documentsfilings and deeds
08-04-202622 days before the deadline
2025micro format
Gross margin from €65,794 to €3,150Loss of €1,278Debts from €47,448 to €16,360Cash from €76,811 to €53,275

Key points

from the 2025 annual accounts

Turnover

≈ €19,000 estimated

The micro format states no turnover.

Liquidity

8.13 was 2.97 in 2024

Short-term debts fell from €45,371 to €12,801.

Position in the sector

-€1,278

Lower net result than 92% of companies in human health. Sector median €59,520 · 21,355 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,152 companies had the same profile as Dr. Katrien Van de Steen has now. Each dot stands for 6 companies, two years later.

91.6%
were still trading
6.0%
stopped another way
2.2%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a small loss

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,152 companies, not a prediction for Dr. Katrien Van de Steen. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 29-09-2022
  • 50 sharesdeed of 03-10-2022
Board & ownership

Recent changes

Registered office moved from Hasselt to Olen The registered office moved from Djef Swennenstraat 9, 3500 Hasselt to Dr.A.Robrechtsstraat 21, 2250 Olen · Board meeting of 07-01-2026 · Gazette deed
First establishment Dr. A. Robrechtsstraat 21, Olen
Registered in the Peppol Directory Reachable for e-invoices through 0208:0791596214
Incorporation Founding capital of €1,000, 50 shares · Founded by · appointed as director · published on 03-10-2022 · Gazette deed
All 10 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Katrien Van de Steen Olen €106,662 €3,150 84.7% -
SELACA Chaudfontaine €137,899 €4,739 56.5% -
DOKTER MEUWISSEN Lommel €186,039 €4,014 99.3% -
JOHEIR MEDICAL Uccle €106,988 €2,645 -15.7% -
BPh Etterbeek €201,368 €5,852 12.8% -
Dr Vanstraelen Sigrid Sint-Truiden €280,072 €3,611 99.9% -
ASCLEPIOS EXPERTISE Namur €49,541 €5,734 7.5% -

These companies have the same main activity as Dr. Katrien Van de Steen: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €49,500 and €280,000, founded between 2015 and 2024.

Official details

Source: KBO
Status
Active since 29-09-2022Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.387.599.8672250 Olen, since 07-01-2026
Financial year end
30 September
Peppol
Reachable since 27-11-2024
Company details

Annual accounts to 30-09-2025

€106,662▼ 23.3%
Filing
Filed on 08-04-2026, 22 days before the end of the filing period
Financials

Insights on Dr. Katrien Van de Steen

Dr. Katrien Van de Steen files the micro format. That format states no turnover. The gross margin fell from €58,421 in 2023 to €3,150 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Katrien Van de Steen

What is the company number of Dr. Katrien Van de Steen?
The company number of Dr. Katrien Van de Steen is 0791.596.214. The VAT number is the same number with BE in front: BE 0791.596.214.
Where is Dr. Katrien Van de Steen based?
The registered office is at Dr. A. Robrechtsstraat 21, 2250 Olen.Company details
What does Dr. Katrien Van de Steen do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Katrien Van de Steen?
Dr. Katrien Van de Steen is a private limited company (BV).
When was Dr. Katrien Van de Steen founded?
Dr. Katrien Van de Steen was founded on 29-09-2022.
Is Dr. Katrien Van de Steen still active?
Yes, Dr. Katrien Van de Steen is an active enterprise in the KBO register.
What is the turnover of Dr. Katrien Van de Steen?
The turnover in financial year 2025 is ≈ €19,000. This figure is estimated from the gross margin of €3,150 and 52 comparable companies (NACE 86). It probably lies between €13,000 and €34,000. It is a rough estimate.Financials
Is Dr. Katrien Van de Steen profitable?
In financial year 2025, Dr. Katrien Van de Steen made a loss of €1,278.
Where can I find the annual accounts of Dr. Katrien Van de Steen?
Dr. Katrien Van de Steen filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Katrien Van de Steen due?
Dr. Katrien Van de Steen must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.